Evidence map›Paper›PMID 41229831›Full record

ArticleJournal of thoracic disease2025

Diagnostic performance of

Jie-Lin Duan, Chun Lu, Ying Jiang, Zhi-Wen Chen, Hong-Kai Wu, Zi-Hao Liu, Pan-Rui Huang, Wei-Jie Guan, Riina Rautemaa-Richardson, Malcolm D Richardson and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. BeyondPathogens (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jie-Lin Duan *State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Chun Lu *State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ying Jiang *State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhi-Wen ChenRichardson Guangzhou Centre for Fungal Diagnostics and Research, Guangzhou, China.
Hong-Kai WuState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zi-Hao LiuState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Pan-Rui HuangState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wei-Jie GuanState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Riina Rautemaa-RichardsonMycology Reference Centre Manchester (MRCM), A European Confederation of Medical Mycology (ECMM) Centre of Excellence, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Malcolm D RichardsonMycology Reference Centre Manchester (MRCM), A European Confederation of Medical Mycology (ECMM) Centre of Excellence, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Christopher P EadesMycology Reference Centre Manchester (MRCM), A European Confederation of Medical Mycology (ECMM) Centre of Excellence, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Lin-Ling ChengState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Elevated serum Methods: We recruited 112 CPA patients and 61 non-CPA controls with pulmonary diseases from The First Affiliated Hospital of Guangzhou Medical University between December 2021 and November 2022. CPA diagnosis followed composite clinical, radiological, and microbiological criteria. Serum Results: 90% of CPA patients had elevated Conclusions: The

Indexed as

Aspergillus-specific immunoglobulin G antibody (Aspergillus-specific IgG antibody)Chronic pulmonary aspergillosis (CPA)diagnostic performanceimmunochromatographic assay

Identifiers

PMID41229831
PMCPMC12603482

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.